SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Clinical trials for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) trials appear
Sign up with your email to follow new studies for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gentler transplant offers hope for kids with rare, Life-Limiting diseases
Disease control Recruiting nowThis study is testing a less intense, potentially safer stem cell transplant procedure for children and young adults with serious inherited disorders like sickle cell disease, immune deficiencies, and metabolic diseases. The goal is to see if using lower doses of chemotherapy bef…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC
-
Real-World watch: tracking a drug for rare, debilitating fevers
Disease control Recruiting nowThis study aims to monitor the safety and effectiveness of the drug Ilaris (canakinumab) in real-world clinical settings. It will include children and adults with rare hereditary fever syndromes or a form of juvenile arthritis who are already receiving the drug as part of their s…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC